These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31721311)

  • 1. The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development.
    Stalder R; Zhang B; Jean Wrobel L; Boehncke WH; Brembilla NC
    Exp Dermatol; 2020 Jan; 29(1):71-78. PubMed ID: 31721311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.
    Kubo S; Yamaoka K; Kondo M; Yamagata K; Zhao J; Iwata S; Tanaka Y
    Ann Rheum Dis; 2014 Dec; 73(12):2192-8. PubMed ID: 24013646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases.
    Vincken NLA; Welsing PMJ; Silva-Cardoso SC; Bekker CPJ; Lopes AP; Olde Nordkamp M; Leijten EFA; Radstake TRDJ; Angiolilli C
    Exp Dermatol; 2022 Jun; 31(6):962-969. PubMed ID: 35297512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients.
    Lethen I; Lechner-Grimm K; Gabel M; Knauss A; Atreya R; Neurath MF; Weigmann B
    Inflamm Bowel Dis; 2024 Jul; 30(7):1151-1163. PubMed ID: 38142236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
    Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
    Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
    Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.
    De Vries LCS; Duarte JM; De Krijger M; Welting O; Van Hamersveld PHP; Van Leeuwen-Hilbers FWM; Moerland PD; Jongejan A; D'Haens GR; De Jonge WJ; Wildenberg ME
    Inflamm Bowel Dis; 2019 Mar; 25(4):647-660. PubMed ID: 30668755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro test system for compounds that modulate human inflammatory macrophage polarization.
    Shiratori H; Feinweber C; Luckhardt S; Wallner N; Geisslinger G; Weigert A; Parnham MJ
    Eur J Pharmacol; 2018 Aug; 833():328-338. PubMed ID: 29920284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicarbonate enhances the inflammatory response by activating JAK/STAT signalling in LPS + IFN-γ-stimulated macrophages.
    Kawakami T; Koike A; Maehara T; Hayashi T; Fujimori K
    J Biochem; 2020 Jun; 167(6):623-631. PubMed ID: 31960927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
    Pagie S; Gérard N; Charreau B
    Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
    Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
    Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
    J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-Derived Dendritic Cell Differentiation in Inflammatory Arthritis Is Regulated by the JAK/STAT Axis via NADPH Oxidase Regulation.
    Marzaioli V; Canavan M; Floudas A; Wade SC; Low C; Veale DJ; Fearon U
    Front Immunol; 2020; 11():1406. PubMed ID: 32733468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib.
    Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y
    Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma.
    Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T
    J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.
    Markikou-Ouni W; Drini S; Bahi-Jaber N; Chenik M; Meddeb-Garnaoui A
    PLoS One; 2015; 10(11):e0143063. PubMed ID: 26581100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing.
    Gaber T; Brinkman ACK; Pienczikowski J; Diesing K; Damerau A; Pfeiffenberger M; Lang A; Ohrndorf S; Burmester GR; Buttgereit F; Hoff P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin.
    Jaguin M; Houlbert N; Fardel O; Lecureur V
    Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
    Kawaguchi Y; Waguri-Nagaya Y; Tatematsu N; Oguri Y; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
    Clin Exp Rheumatol; 2018; 36(4):559-567. PubMed ID: 29352846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.